Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...

Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat NPDR.

Researchers have observed in a new study that stress hyperglycemia (SHR) ratio could be a useful predictor of neovascular ...

VX01-DR-201, is a phase 2, multi-center, double-masked, randomized, placebo-controlled study in patients with moderate to ...

Vasan Eye Care continues to pave the way for better vision and overall improved quality of life for everyone ...

Diabetic retinopathy; NHMRC: National Health and Medical Research Council; NPDR: Nonproliferative DR; PDR: Proliferative DR; RCO: Royal College of Ophthalmologists. NHMRC Dilated ophthalmoscopy or ...

India holds the unenviable position of being home to the world’s largest diabetic population, with nearly 100 million ...

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic ...

They included adults with type 2 diabetes initiating study drugs without prior diagnosis or treatment for proliferative diabetic retinopathy or other advanced retinal diseases. For the incident ...

Loss to follow-up was higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 ...